| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.54▼ | 2.54▼ | 2.55▼ | 2.62▼ | 2.92▼ |
| MA10 | 2.55▼ | 2.55▼ | 2.54▼ | 2.69▼ | 3.07▼ |
| MA20 | 2.55▼ | 2.54▼ | 2.56▼ | 2.86▼ | 2.48▲ |
| MA50 | 2.55▼ | 2.62▼ | 2.68▼ | 3.00▼ | 2.06▲ |
| MA100 | 2.56▼ | 2.69▼ | 2.77▼ | 2.45▲ | 2.02▲ |
| MA200 | 2.62▼ | 2.77▼ | 3.10▼ | 2.08▲ | 1.51▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | 0.002▲ | 0.004▲ | -0.047▼ | -0.018▼ |
| RSI | 33.641▼ | 35.988▼ | 33.464▼ | 38.365▼ | 50.728▲ |
| STOCH | 43.333 | 26.566 | 36.398 | 19.989▼ | 50.045 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -98.649▼ | -69.547 |
| CCI | -168.641▼ | -221.223▼ | -134.390▼ | -151.020▼ | -12.415 |
|
Saturday, October 25, 2025 08:52 AM
Detailed price information for Fortress Biotech Inc (FBIO-Q) from The Globe and Mail including charting and trades.
|
|
Saturday, October 25, 2025 08:52 AM
Detailed price information for Fortress Biotech Inc (FBIO-Q) from The Globe and Mail including charting and trades.
|
|
Tuesday, October 21, 2025 07:15 AM
Urica Therapeutics, a majority-owned subsidiary of Fortress, reported that Crystalys Therapeutics has dosed the first patients in two global Phase 3 trials evaluating dotinurad, a once-daily oral ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/10/25 | 2.555 | 2.59 | 2.50 | 2.51 | 365,668 |
| 23/10/25 | 2.64 | 2.645 | 2.51 | 2.52 | 551,869 |
| 22/10/25 | 2.75 | 2.79 | 2.52 | 2.54 | 622,768 |
| 21/10/25 | 2.73 | 2.87 | 2.71 | 2.77 | 385,887 |
| 20/10/25 | 2.79 | 2.815 | 2.66 | 2.76 | 578,438 |
| 17/10/25 | 2.72 | 2.76 | 2.67 | 2.70 | 354,964 |
| 16/10/25 | 2.84 | 2.90 | 2.695 | 2.74 | 726,532 |
| 15/10/25 | 2.76 | 2.83 | 2.705 | 2.82 | 391,326 |
| 14/10/25 | 2.70 | 2.78 | 2.592 | 2.73 | 489,527 |
| 13/10/25 | 2.71 | 2.83 | 2.7018 | 2.80 | 416,101 |
|
|
||||
|
|
||||
|
|